CTOs on the Move

Tko Surgical

www.tkosurgical.com

 
Tko Surgical is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Biosense Webster

Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at

eScan Data Systems

eScan Data Systems is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IDEX Health

IDEX Health & Science is the global authority in fluidics and optics` bringing life to advanced optofluidic technologies with our products` people and engineering expertise. We are respected worldwide for solving complex problems and delivering complete path innovation for analytical` diagnostic and biotechnology applications for the life sciences market. As a genuine and trustworthy partner` we solve our customers’ most demanding challenges with the industry`s most extensive portfolio of state-of-the-art components and capabilities that are unrivaled in breadth` quality` performance and design. Our vision of the complete path goes far beyond just meeting our customers’ needs — it anticipates them` with intelligent solutions for life.

Urodynamix Technologies

Urodynamix Technologies Ltd. is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GT Medical Technologies

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.